MAP Pharmaceuticals' Series C Round

MAP Pharmaceuticals raised a round of funding on January 16, 2006.

MAP Pharmaceuticals is a drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place bette…

Articles about MAP Pharmaceuticals' Series C Round: